ArticleDiscover oncology2025

Histone demethylase JMJD2D emerges as a novel prognostic biomarker and exhibits correlation with immune infiltration in lung adenocarcinoma.

Bona Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.